Joanna L Stollings1, Sarah L Bloom1, Li Wang1, E Wesley Ely1,2, James C Jackson2,3, Carla M Sevin1. 1. 1 Vanderbilt University Medical Center, Nashville, TN, USA. 2. 2 Department of Veterans Affairs Medical Center Tennessee Valley Healthcare System, Nashville, TN, USA. 3. 3 Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract
BACKGROUND: Many patients experience complications following critical illness; these are now widely referred to as post-intensive care syndrome (PICS). An interprofessional intensive care unit (ICU) recovery center (ICU-RC), also known as a PICS clinic, is one potential approach to promoting patient and family recovery following critical illness. OBJECTIVES: To describe the role of an ICU-RC critical care pharmacist in identifying and treating medication-related problems among ICU survivors. METHODS: A prospective, observational cohort study was conducted of all outpatient appointments of a tertiary care hospital's ICU-RC between July 2012 and December 2015. The pharmacist completed a full medication review, including medication reconciliation, interview, counseling, and resultant interventions, during the ICU-RC appointment. RESULTS: Data from all completed ICU-RC visits were analyzed (n = 62). A full medication review was performed in 56 (90%) of these patients by the pharmacist. The median number of pharmacy interventions per patient was 4 (interquartile range = 2, 5). All 56 patients had at least 1 pharmacy intervention; 22 (39%) patients had medication(s) stopped at the clinic appointment, and 18 (32%) patients had new medication(s) started. The pharmacist identified 9 (16%) patients who had an adverse drug event (ADE); 18 (32%) patients had ADE preventive measures instituted. An influenza vaccination was administered to 13 (23%) patients despite an inpatient protocol to ensure influenza vaccination prior to discharge. A pneumococcal vaccination was administered to 2 (4%) patients. CONCLUSIONS: Use of a critical care pharmacist resulted in the identification and treatment of multiple medication-related problems in an ICU-RC as well as implementation of preventive measures.
BACKGROUND: Many patients experience complications following critical illness; these are now widely referred to as post-intensive care syndrome (PICS). An interprofessional intensive care unit (ICU) recovery center (ICU-RC), also known as a PICS clinic, is one potential approach to promoting patient and family recovery following critical illness. OBJECTIVES: To describe the role of an ICU-RC critical care pharmacist in identifying and treating medication-related problems among ICU survivors. METHODS: A prospective, observational cohort study was conducted of all outpatient appointments of a tertiary care hospital's ICU-RC between July 2012 and December 2015. The pharmacist completed a full medication review, including medication reconciliation, interview, counseling, and resultant interventions, during the ICU-RC appointment. RESULTS: Data from all completed ICU-RC visits were analyzed (n = 62). A full medication review was performed in 56 (90%) of these patients by the pharmacist. The median number of pharmacy interventions per patient was 4 (interquartile range = 2, 5). All 56 patients had at least 1 pharmacy intervention; 22 (39%) patients had medication(s) stopped at the clinic appointment, and 18 (32%) patients had new medication(s) started. The pharmacist identified 9 (16%) patients who had an adverse drug event (ADE); 18 (32%) patients had ADE preventive measures instituted. An influenza vaccination was administered to 13 (23%) patients despite an inpatient protocol to ensure influenza vaccination prior to discharge. A pneumococcal vaccination was administered to 2 (4%) patients. CONCLUSIONS: Use of a critical care pharmacist resulted in the identification and treatment of multiple medication-related problems in an ICU-RC as well as implementation of preventive measures.
Entities:
Keywords:
adverse drug event; medication reconciliation; pharmacist; post–intensive care syndrome; post–intensive care syndrome clinic
Authors: Mark Unroe; Jeremy M Kahn; Shannon S Carson; Joseph A Govert; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice Gray; James A Tulsky; Christopher E Cox Journal: Ann Intern Med Date: 2010-08-03 Impact factor: 25.391
Authors: Elizabeth L Huggins; Sarah L Bloom; Joanna L Stollings; Mildred Camp; Carla M Sevin; James C Jackson Journal: AACN Adv Crit Care Date: 2016 Apr-Jun
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Jennifer R Pippins; Tejal K Gandhi; Claus Hamann; Chima D Ndumele; Stephanie A Labonville; Ellen K Diedrichsen; Marcy G Carty; Andrew S Karson; Ishir Bhan; Christopher M Coley; Catherine L Liang; Alexander Turchin; Patricia C McCarthy; Jeffrey L Schnipper Journal: J Gen Intern Med Date: 2008-06-19 Impact factor: 5.128
Authors: Kyle A Weant; John A Armitstead; Alim M Ladha; Deanna Sasaki-Adams; Eldad J Hadar; Matthew G Ewend Journal: Neurosurgery Date: 2009-11 Impact factor: 4.654
Authors: Karalea D Jasiak; Ellen A Middleton; James M Camamo; Brian L Erstad; Linda S Snyder; Yvonne C Huckleberry Journal: J Pharm Pract Date: 2012-11-26
Authors: John W Devlin; Francois Marquis; Richard R Riker; Tracey Robbins; Erik Garpestad; Jeffrey J Fong; Dorothy Didomenico; Yoanna Skrobik Journal: Crit Care Date: 2008-02-21 Impact factor: 9.097
Authors: Joanne McPeake; Eliotte L Hirshberg; Leeann M Christie; Kelly Drumright; Kimberley Haines; Catherine L Hough; Joel Meyer; Dorothy Wade; Adair Andrews; Rita Bakhru; Samantha Bates; John A Barwise; Julie Bastarache; Sarah J Beesley; Leanne M Boehm; Sheryl Brown; Alison S Clay; Penelope Firshman; Steven Greenberg; Wendy Harris; Christopher Hill; Carol Hodgson; Clare Holdsworth; Aluko A Hope; Ramona O Hopkins; David C J Howell; Anna Janssen; James C Jackson; Annie Johnson; Erin K Kross; Daniela Lamas; Belinda MacLeod-Smith; Ruth Mandel; John Marshall; Mark E Mikkelsen; Megan Nackino; Tara Quasim; Carla M Sevin; Andrew Slack; Rachel Spurr; Mary Still; Carol Thompson; Gerald Weinhouse; M Elizabeth Wilcox; Theodore J Iwashyna Journal: Crit Care Med Date: 2019-01 Impact factor: 7.598
Authors: Stephanie Parks Taylor; Shih-Hsiung Chou; Marielys Figueroa Sierra; Thomas P Shuman; Andrew D McWilliams; Brice T Taylor; Mark Russo; Susan L Evans; Whitney Rossman; Stephanie Murphy; Kyle Cunningham; Marc A Kowalkowski Journal: Ann Am Thorac Soc Date: 2020-01
Authors: Antoinette B Coe; Rebecca E Bookstaver; Andrew C Fritschle; Michael T Kenes; Pamela MacTavish; Rima A Mohammad; Robert J Simonelli; Jessica A Whitten; Joanna L Stollings Journal: Hosp Pharm Date: 2019-01-28
Authors: Pamela MacTavish; Tara Quasim; Martin Shaw; Helen Devine; Malcolm Daniel; John Kinsella; Carl Fenelon; Rakesh Kishore; Theodore J Iwashyna; Joanne McPeake Journal: BMJ Open Qual Date: 2019-09-27
Authors: Robert P Kosilek; Sebastian E Baumeister; Till Ittermann; Matthias Gründling; Frank M Brunkhorst; Stephan B Felix; Peter Abel; Sigrun Friesecke; Christian Apfelbacher; Magdalena Brandl; Konrad Schmidt; Wolfgang Hoffmann; Carsten O Schmidt; Jean-François Chenot; Henry Völzke; Jochen S Gensichen Journal: PLoS One Date: 2019-09-20 Impact factor: 3.240
Authors: Narjes Akhlaghi; Dale M Needham; Somnath Bose; Valerie M Banner-Goodspeed; Sarah J Beesley; Victor D Dinglas; Danielle Groat; Tom Greene; Ramona O Hopkins; James Jackson; Mustafa Mir-Kasimov; Carla M Sevin; Emily Wilson; Samuel M Brown Journal: BMJ Open Date: 2020-10-23 Impact factor: 2.692
Authors: Carla M Sevin; Leanne M Boehm; Elizabeth Hibbert; Anthony J Bastin; James C Jackson; Joel Meyer; Tara Quasim; Rita N Bakhru; Ashley Montgomery-Yates; Andrew Slack; Mary Still; Giora Netzer; Mark E Mikkelsen; Theodore J Iwashyna; Kimberley J Haines; Joanne McPeake Journal: Crit Care Explor Date: 2021-05-12